Testosterone shots aim to boost Well-Being in End-of-Life care
NCT ID NCT07143279
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving testosterone injections every 15 days can improve quality of life for men with low testosterone who are receiving best supportive care and have no further treatment options. Researchers will track symptoms like pain, fatigue, and daily living activities using questionnaires. The goal is to see if this hormone therapy can ease symptoms and help maintain independence.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOTESTOSTERONISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut Jules Bordet
RECRUITINGBrussels, 1070, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Training healthcare teams to see the whole person behind the illness
- A 6-week coaching program may lift the weight on family caregivers — a study asks if it works.
- Can a simple text message transform cancer care?
- Can a 30-hour e-learning course equip family doctors to deliver better palliative care?
- Mushroom extract put to the test for advanced cancer Well-Being
- A simple lesson before discharge could ease the heavy load on family caregivers